GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » PhotoCure ASA (OSL:PHO) » Definitions » Cyclically Adjusted Revenue per Share

PhotoCure ASA (OSL:PHO) Cyclically Adjusted Revenue per Share : kr13.85 (As of Mar. 2025)


View and export this data going back to 2000. Start your Free Trial

What is PhotoCure ASA Cyclically Adjusted Revenue per Share?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

PhotoCure ASA's adjusted revenue per share for the three months ended in Mar. 2025 was kr4.672. Add all the adjusted revenue per share for the past 10 years together and divide the count will get our Cyclically Adjusted Revenue per Share, which is kr13.85 for the trailing ten years ended in Mar. 2025.

During the past 12 months, PhotoCure ASA's average Cyclically Adjusted Revenue Growth Rate was 11.30% per year. During the past 3 years, the average Cyclically Adjusted Revenue Growth Rate was 14.00% per year. During the past 5 years, the average Cyclically Adjusted Revenue Growth Rate was 12.40% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Revenue Growth Rate using Cyclically Adjusted Revenue per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted Revenue Growth Rate of PhotoCure ASA was 14.90% per year. The lowest was 8.40% per year. And the median was 10.90% per year.

As of today (2025-06-22), PhotoCure ASA's current stock price is kr50.50. PhotoCure ASA's Cyclically Adjusted Revenue per Share for the quarter that ended in Mar. 2025 was kr13.85. PhotoCure ASA's Cyclically Adjusted PS Ratio of today is 3.65.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of PhotoCure ASA was 17.97. The lowest was 3.59. And the median was 6.81.


PhotoCure ASA Cyclically Adjusted Revenue per Share Historical Data

The historical data trend for PhotoCure ASA's Cyclically Adjusted Revenue per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

PhotoCure ASA Cyclically Adjusted Revenue per Share Chart

PhotoCure ASA Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Cyclically Adjusted Revenue per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 7.95 9.08 10.26 12.07 13.44

PhotoCure ASA Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Cyclically Adjusted Revenue per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 12.44 12.91 12.99 13.44 13.85

Competitive Comparison of PhotoCure ASA's Cyclically Adjusted Revenue per Share

For the Drug Manufacturers - Specialty & Generic subindustry, PhotoCure ASA's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


PhotoCure ASA's Cyclically Adjusted PS Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, PhotoCure ASA's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where PhotoCure ASA's Cyclically Adjusted PS Ratio falls into.


;
;

PhotoCure ASA Cyclically Adjusted Revenue per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

What is Cyclically Adjusted Revenue per Share? How do we calculate Cyclically Adjusted Revenue per Share?

Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Revenue per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the revenue per share from 2001 through 2010.

We adjusted the 2001 revenue per share data with the total inflation from 2001 through 2010 to the equivalent revenue in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's revenue is $1 a share in 2001, then the 2001's equivalent revenue in 2010 is $1.4 a share. If Wal-Mart's revenue is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 revenue in 2010 is $1.35. So on and so forth, you get the equivalent revenue per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, PhotoCure ASA's adjusted Revenue per Share data for the three months ended in Mar. 2025 was:

Adj_RevenuePerShare= Revenue per Share /CPI of Mar. 2025 (Change)*Current CPI (Mar. 2025)
=4.672/136.1000*136.1000
=4.672

Current CPI (Mar. 2025) = 136.1000.

PhotoCure ASA Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201506 1.639 100.100 2.228
201509 1.658 100.600 2.243
201512 1.589 100.900 2.143
201603 1.481 102.500 1.966
201606 1.645 103.800 2.157
201609 1.635 104.200 2.136
201612 1.741 104.400 2.270
201703 1.687 105.000 2.187
201706 1.843 105.800 2.371
201709 1.664 105.900 2.139
201712 1.811 106.100 2.323
201803 1.921 107.300 2.437
201806 2.127 108.500 2.668
201809 2.047 109.500 2.544
201812 2.268 109.800 2.811
201903 2.445 110.400 3.014
201906 2.466 110.600 3.035
201909 2.854 111.100 3.496
201912 5.307 111.300 6.490
202003 2.515 111.200 3.078
202006 2.273 112.100 2.760
202009 1.856 112.900 2.237
202012 3.666 112.900 4.419
202103 3.314 114.600 3.936
202106 3.408 115.300 4.023
202109 3.232 117.500 3.744
202112 3.628 118.900 4.153
202203 3.044 119.800 3.458
202206 3.705 122.600 4.113
202209 3.978 125.600 4.311
202212 3.838 125.900 4.149
202303 3.908 127.600 4.168
202306 5.356 130.400 5.590
202309 4.043 129.800 4.239
202312 4.974 131.900 5.132
202403 4.355 132.600 4.470
202406 5.308 133.800 5.399
202409 4.509 133.700 4.590
202412 5.142 134.800 5.192
202503 4.672 136.100 4.672

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.


PhotoCure ASA  (OSL:PHO) Cyclically Adjusted Revenue per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Revenue per Share may underestimate the company's revenue. Cyclically Adjusted PS Ratio can seem to be too high even the actual PS Ratio is low.

For the Cyclically Adjusted PS Ratio, the revenue per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/S calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PS Ratio is also called CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

PhotoCure ASA's Cyclically Adjusted PS Ratio of today is calculated as

Cyclically Adjusted PS Ratio=Share Price/Cyclically Adjusted Revenue per Share
=50.50/13.85
=3.65

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of PhotoCure ASA was 17.97. The lowest was 3.59. And the median was 6.81.


Be Aware

Cyclically Adjusted PS Ratio works better for cyclical companies. It gives you a better idea on the company's real revenue value.


PhotoCure ASA Cyclically Adjusted Revenue per Share Related Terms

Thank you for viewing the detailed overview of PhotoCure ASA's Cyclically Adjusted Revenue per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


PhotoCure ASA Business Description

Industry
Address
Hoffsveien 4, Oslo, NOR, 0275
PhotoCure ASA is a Norway-based business group associated with the research, development, production, distribution, marketing, and sales of pharmaceutical products and specialty pharmaceutical companies. The technology platform of the company is focused on the field of photodynamic diagnosis and treatment of cancer. The company has two operating segments of the group the Commercial franchise and the Development portfolio. It generates prime revenue from the Commercial franchise segment, which includes Hexvix and Cysview products. Its geographical segments are Nordic countries, Germany, France, Austria, the United Kingdom, BeNeLux, Italy, Other European countries, Canada, and the United States.

PhotoCure ASA Headlines